Literature DB >> 23020526

Peritoneal macrophages mediated delivery of chitosan/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model.

Isabel Nawroth1, Jan Alsner, Bent W Deleuran, Frederik Dagnaes-Hansen, Chuanxu Yang, Michael R Horsman, Jens Overgaard, Kenneth A Howard, Jørgen Kjems, Shan Gao.   

Abstract

BACKGROUND: Radiation-induced fibrosis (RIF) is a dose-limiting complication of cancer radiotherapy and causes serious problems, i.e. restricted tissue flexibility, pain, ulceration or necrosis. Recently, we have successfully treated RIF in a mouse model by intraperitoneal administration of chitosan/siRNA nanoparticles directed towards silencing TNF alpha in local macrophage populations, but the mechanism for the therapeutic effect at the lesion site remains unclear.
METHODS: Using the same murine RIF model we utilized an optical imaging technique and fluorescence microscopy to investigate the uptake of chitosan/fluorescently labeled siRNA nanoparticles by peritoneal macrophages and their subsequent migration to the inflamed tissue in the RIF model.
RESULTS: We observed strong accumulation of the fluorescent signal in the lesion site of the irradiated leg up to 24 hours using the optical imaging system. We further confirm by immunohistochemical staining that Cy3 labeled siRNA resides in macrophages of the irradiated leg.
CONCLUSION: We provide a proof-of-concept for host macrophage trafficking towards the inflamed region in a murine RIF model, which thereby suggests that the chitosan/siRNA nanoparticle may constitute a general treatment for inflammatory diseases using the natural homing potential of macrophages to inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020526     DOI: 10.3109/0284186X.2012.726373

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Loss of CD73 prevents accumulation of alternatively activated macrophages and the formation of prefibrotic macrophage clusters in irradiated lungs.

Authors:  Simone de Leve; Florian Wirsdörfer; Federica Cappuccini; Alexandra Schütze; Alina V Meyer; Katharina Röck; Linda F Thompson; Jens W Fischer; Martin Stuschke; Verena Jendrossek
Journal:  FASEB J       Date:  2017-03-21       Impact factor: 5.191

2.  Assessment of Physicochemical and In Vivo Biological Properties of Polymeric Nanocapsules Based on Chitosan and Poly(N-vinyl pyrrolidone-alt-itaconic anhydride).

Authors:  Kheira Zanoune Dellali; Mohammed Dellali; Delia Mihaela Raţă; Anca Niculina Cadinoiu; Leonard Ionut Atanase; Marcel Popa; Mihaela-Claudia Spataru; Carmen Solcan
Journal:  Polymers (Basel)       Date:  2022-04-28       Impact factor: 4.967

Review 3.  Current Development of Nano-Drug Delivery to Target Macrophages.

Authors:  Donglin Cai; Wendong Gao; Zhelun Li; Yufeng Zhang; Lan Xiao; Yin Xiao
Journal:  Biomedicines       Date:  2022-05-23

4.  Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice.

Authors:  Chuanxu Yang; Line Nilsson; Muhammad Umar Cheema; Yan Wang; Jørgen Frøkiær; Shan Gao; Jørgen Kjems; Rikke Nørregaard
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

5.  Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer.

Authors:  Mi Zhou; Jiaqi Dong; Junqing Huang; Wen Ye; Zhousan Zheng; Kangbo Huang; Yihui Pan; Junjie Cen; Yanping Liang; Guannan Shu; Sheng Ye; Xuanxuan Lu; Jiaxing Zhang
Journal:  Adv Sci (Weinh)       Date:  2022-06-19       Impact factor: 17.521

6.  Chitosan hydrogel as siRNA vector for prolonged gene silencing.

Authors:  Zhiwei Ma; Chuanxu Yang; Wen Song; Qintao Wang; Jørgen Kjems; Shan Gao
Journal:  J Nanobiotechnology       Date:  2014-06-19       Impact factor: 10.435

7.  Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid Nanoparticles.

Authors:  Thanh-Huyen Tran; Ruchir Rastogi; Juili Shelke; Mansoor M Amiji
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

Review 8.  The CD73/Ado System-A New Player in RT Induced Adverse Late Effects.

Authors:  Simone de Leve; Florian Wirsdörfer; Verena Jendrossek
Journal:  Cancers (Basel)       Date:  2019-10-16       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.